Effect of intramyometrial injection of carbetocin versus rectal misoprostol on blood loss during myomectomy

Effect of intramyometrial injection of carbetocin versus rectal misoprostol on blood loss during myomectomy - Effect of intramyometrial injection of carbetocin versus rectal misoprostol on blood loss during myomecttomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029747

Enrollment

Registered

2018-12-01

Start date

2018-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recruiting

Interventions

Intramyometrial injection of carbetocin during operation of myomectomy rectal misoprostol preoperative

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Intramural myoma >= 4cm single myoma symptomatic myoma

Exclusion criteria

Exclusion criteria: Previous operation either myomectomy or cesarean section Any bleeding disorders Any medical disease eg: hypertension, renal, liver or heart diesase Any myoma rather than intramural

Design outcomes

Primary

Measure	Time frame
Intraoperative Blood loss during myomectomy Operative time	—

Secondary

Measure	Time frame
operative complications Hematocrit after 24 hours of operation	—

Countries

Africa

Contacts

Public ContactAyman Dawood

Tanta university Obstetrics and gynecology

ayman.dawood@med.tanta.edu.eg+201020972067

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026